Literature DB >> 2602781

Tropical disease in the immunocompromised host: melioidosis and pythiosis.

D Tanphaichitra1.   

Abstract

Melioidosis is an infection of humans and animals caused by a gram-negative motile bacillus, Pseudomonas pseudomallei. Forty-nine patients with melioidosis complicating diabetes mellitus, collagen vascular disorders, leukemia/lymphoma, and other hematologic malignancies are described. Twenty-nine of these patients had disseminated/septicemic infection, two developed toxic shock syndrome, and one with AIDS experienced recrudescent melioidosis. Patients with disseminated melioidosis often have a variety of defects in cellular immunity both in vitro and in vivo. In humans with recrudescent melioidosis, cellular immunity can be transferred by a transfer factor and by levamisole, a cellular immunopotentiating agent. The results of the treatment of our patients with disseminated/septicemic melioidosis with antimicrobial agents in combination have been successful. In recent years, four cases of fungal arteritis due to Pythium species and one case of keratitis due to Pythium were seen. Almost all patients with fungal arteritis had thalassemia; all presented with pain in the lower extremities and gangrenous lesions of the toes. Pythium species, an aquatic Phycomycetes, was identified in these cases as a human pathogen on the basis of clinical features, pathologic findings, and--of greatest importance--the isolation of the etiologic fungi. These five cases with remarkably similar presentations exhibited certain similarities with and differences from cases of mucormycosis, entomophthoromycosis, and peniciliosis.

Entities:  

Mesh:

Year:  1989        PMID: 2602781     DOI: 10.1093/clinids/11.supplement_7.s1629

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  11 in total

Review 1.  Tropical respiratory medicine. 1. Pulmonary infections in the tropics: impact of HIV infection.

Authors:  C L Daley
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

2.  In vitro activity of tosufloxacin against Pseudomonas pseudomallei, Salmonella spp. and other Enterobacteriaceae.

Authors:  S Srimuang; V Fugpholngam; K Asvanich; A Chongchitmate; D Tanphaichitra
Journal:  Drugs       Date:  1995       Impact factor: 9.546

3.  Identification of a novel 74-kiloDalton immunodominant antigen of Pythium insidiosum recognized by sera from human patients with pythiosis.

Authors:  Theerapong Krajaejun; Mongkol Kunakorn; Rungnapa Pracharktam; Piriyaporn Chongtrakool; Boonmee Sathapatayavongs; Angkana Chaiprasert; Nongnuch Vanittanakom; Ariya Chindamporn; Piroon Mootsikapun
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  Development and evaluation of an in-house enzyme-linked immunosorbent assay for early diagnosis and monitoring of human pythiosis.

Authors:  Theerapong Krajaejun; Mongkol Kunakorn; Sopaporn Niemhom; Piriyaporn Chongtrakool; Roongnapa Pracharktam
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 5.  Human pythiosis in Thailand.

Authors:  P Imwidthaya
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

6.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

7.  Musculoskeletal melioidosis: clinical and imaging features.

Authors:  M H Pui; A P Tan
Journal:  Skeletal Radiol       Date:  1995-10       Impact factor: 2.199

8.  Development of an immunochromatographic test for rapid serodiagnosis of human pythiosis.

Authors:  Theerapong Krajaejun; Srisurat Imkhieo; Akarin Intaramat; Kavi Ratanabanangkoon
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

9.  Siderophore production by Pseudomonas pseudomallei.

Authors:  H M Yang; W Chaowagul; P A Sokol
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Ribotype analysis of Pseudomonas pseudomallei isolates.

Authors:  M M Sexton; L A Goebel; A J Godfrey; W Choawagul; N J White; D E Woods
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.